Indian Embassy in Beijing Issues Comprehensive FAQ for Returning Students
The Indian Embassy in Beijing has released a detailed FAQ to guide Indian students on attesting their Chinese degrees. The FAQ addresses fees, timeframes, and essential procedures, including verifications needed for acceptance in India. This comes after an interactive session addressing COVID-19 disruptions faced by students.
- Country:
- China
The Indian Embassy in Beijing has released a comprehensive FAQ to assist Indian students in China regarding attestation procedures for their Chinese degrees. This critical information aims to aid students from the 2016, 2017, and 2018 batches who plan to return to India in June and July.
The FAQ outlines the fees charged by the embassy and Indian consulates in Shanghai and Guangzhou, the time required for document attestation, including fast-track options, and the necessity of such attestations for acceptance in India. It also covers the verification process for documents sent by various Indian medical councils to the Embassy.
This initiative follows an interactive session held last month where Indian Ambassador to China Pradeep Kumar Rawat and Counsellor Nitinjeet Singh addressed students' COVID-19 related grievances. Second Secretary Amit Sharma presented on the services offered by the Embassy and provided guidelines for students studying in China.
Prior to the pandemic, over 23,000 Indian students were in China, primarily studying medicine. Current numbers have reduced to about 8,000. Many Indian students had to leave China during the lockdowns and only recently returned after diplomatic efforts by the Indian Embassy.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
FDA Shifts COVID-19 Vaccine Strategy to KP.2 Variant for 2024-25
FDA Revises COVID-19 Vaccine Targets to KP.2 Strain
Asia's Wake-Up Call: Strengthening Health Systems Post-COVID-19
China Accuses U.S. Military of Hypocrisy Amid COVID-19 Vaccine Propaganda
Kansas Sues Pfizer: Allegations of Misleading COVID-19 Vaccine Claims